Related Experiment Video

Updated: Jul 5, 2026

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

House dust mite control measures for asthma: systematic review

P C Gøtzsche1, H K Johansen

  • 1Nordic Cochrane Centre, Rigshospitalet, Copenhagen, Denmark.

Allergy
|May 1, 2008
PubMed

Insights

Reducing exposure to house dust mites through physical or chemical interventions does not improve asthma symptoms or lung function in allergic individuals. This systematic review found no significant benefits from these common allergen-avoidance strategies.

Area of Science:

  • Allergy and Immunology
  • Environmental Health
  • Respiratory Medicine

Background:

  • House dust mites are a primary source of allergens for individuals with asthma.
  • Reducing exposure to these allergens is a common strategy for managing mite-sensitive asthma.

Purpose of the Study:

  • To systematically review randomized controlled trials evaluating the efficacy of reducing house dust mite allergen exposure in mite-sensitive asthma patients.
  • To compare active interventions against placebo or no treatment.

Main Methods:

  • Systematic review of 54 randomized trials involving 3002 patients.
  • Interventions included physical methods (e.g., mattress covers), chemical methods, and combined approaches.
  • Outcomes assessed included peak flow, patient improvement, symptom scores, and medication use.

Main Results:

  • No statistically significant differences were observed in peak morning flow (SMD 0.00), patient improvement (RR 1.01), asthma symptom scores (SMD -0.04), or medication usage (SMD -0.06).
  • Despite potential exaggeration of effects due to trial quality, interventions showed no benefit.
  • Confidence intervals for all primary outcomes included the null value.

Conclusions:

  • Current chemical and physical methods for reducing house dust mite allergen exposure are not recommended for managing mite-sensitive asthma.
  • Evidence does not support the routine use of these allergen-avoidance strategies based on the reviewed trials.

More Related Videos

Methodology for Sputum Induction and Laboratory Processing13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include: